Advertisement
| birth control hormone therapy: Hormonal Contraception and Post-menopausal Hormonal Therapy IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 1999 Evaluates evidence for an increased risk of cancer in women using combined oral contraceptives, progestogen-only hormonal contraceptives, post-menopausal estrogen therapy, and post-menopausal estrogen-progestogen therapy. Although the carcinogenicity of these preparations has been extensively investigated, the book stresses the many complex methodological issues that must be considered when interpreting findings and weighing results. Evidence of an association between use of these preparations and positive effects on health, including a reduced risk of some cancers, is also critically assessed. The first and most extensive monograph evaluates evidence of an association between the use of combined oral contraceptives and cancer at nine sites. Concerning breast cancer, the evaluation concludes that, even if the association is causal, the excess risk for breast cancer associated with patterns of use that are typical today is very small. Studies of predominantly high-dose preparations found an increased risk of hepatocellular carcinoma in the absence of hepatitis viruses. Citing these findings, the evaluation concludes that there is sufficient evidence in humans for the carcinogenicity of combined oral contraceptives. The evaluation also found sufficient evidence for the carcinogenicity of some, but not all, combined preparations in animals. Combined oral contraceptives were classified as carcinogenic to humans. The evaluation also cites conclusive evidence that these agents have a protective effect against cancers of the ovary and endometrium. Progestogen-only contraceptives are evaluated in the second monograph, which considers the association with cancer at six sites. The evaluation found no evidence of an increased risk for breast cancer. Although the evaluation found sufficient evidence in animals for the carcinogenicity of medroxyprogesterone acetate, evidence for the carcinogenicity of progestogen-only contraceptives in humans was judged inadequate. Progestogen-only contraceptives were classified as possibly carcinogenic to humans. The third monograph, on post-menopausal estrogen therapy, considers evidence of an association with cancer at eight sites. Findings from a large number of epidemiological studies indicate a small increase in the risk of breast cancer in women who have used these preparations for five years or more. Studies consistently show an association between use of post-menopausal estrogen therapy and an increased risk for endometrial cancer. Data on the association with other cancers were either inconclusive or suggested no effect on risk. The evaluation concludes that post-menopausal estrogen therapy is carcinogenic to humans. The final monograph evaluates the association between the use of post-menopausal estrogen-progestogen therapy and cancer at four sites. The evaluation of limited data on breast cancer found an increased relative risk observed with long-term use. Data were judged insufficient to assess the effects of past use and of different progestogen compounds, doses, and treatment schedules. For endometrial cancer, the evaluation found an increase in risk relative to non-users when the progestogen was added to the cycle for 10 days or fewer. Post-menopausal estrogen-progestogen therapy was classified as possibly carcinogenic to humans. Concerning post-menopausal therapy in general, the book notes that evidence of carcinogenic risks must be placed in perspective of potential benefits. The prevention of osteoporotic fractures is cited as the best-established benefit. Evidence also suggests that estrogen prevents heart disease and may prevent memory loss and dementia. |
| birth control hormone therapy: Selected Practice Recommendations for Contraceptive Use World Health Organization. Reproductive Health and Research, World Health Organization, World Health Organization. Family and Community Health, 2005 This document is one of two evidence-based cornerstones of the World Health Organization's (WHO) new initiative to develop and implement evidence-based guidelines for family planning. The first cornerstone, the Medical eligibility criteria for contraceptive use (third edition) published in 2004, provides guidance for who can use contraceptive methods safely. This document, the Selected practice recommendations for contraceptive use (second edition), provides guidance for how to use contraceptive methods safely and effectively once they are deemed to be medically appropriate. The recommendations contained in this document are the product of a process that culminated in an expert Working Group meeting held at the World Health Organization, Geneva, 13-16 April 2004. |
| birth control hormone therapy: Medical Eligibility Criteria for Contraceptive Use , 2010 Medical Eligibility Criteria for Contraceptive Use reviews the medical eligibility criteria for use of contraception, offering guidance on the safety and use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research. It is a companion guideline to Selected Practice Recommendations for Contraceptive Use. Together, these documents are intended to be used by policy-makers, program managers, and the scientific community to support national programs in the preparation of service delivery guidelines. The fourth edition of this useful resource supersedes previous editions, and has been fully updated and expanded. It includes over 86 new recommendations and 165 updates to recommendations in the previous edition. Guidance for populations with special needs is now provided, and a new annex details evidence on drug interactions from concomitant use of antiretroviral therapies and hormonal contraceptives. To assist users familiar with the third edition, new and updated recommendations are highlighted. Everyone involved in providing family planning services and contraception should have the fourth edition of Medical Eligibility Criteria for Contraceptive Use at hand. |
| birth control hormone therapy: This Is Your Brain on Birth Control Sarah Hill, 2019-10-01 An eye-opening book that reveals crucial information every woman taking hormonal birth control should know This groundbreaking book sheds light on how hormonal birth control affects women--and the world around them--in ways we are just now beginning to understand. By allowing women to control their fertility, the birth control pill has revolutionized women's lives. Women are going to college, graduating, and entering the workforce in greater numbers than ever before, and there's good reason to believe that the birth control pill has a lot to do with this. But there's a lot more to the pill than meets the eye. Although women go on the pill for a small handful of targeted effects (pregnancy prevention and clearer skin, yay!), sex hormones can't work that way. Sex hormones impact the activities of billions of cells in the body at once, many of which are in the brain. There, they play a role in influencing attraction, sexual motivation, stress, hunger, eating patterns, emotion regulation, friendships, aggression, mood, learning, and more. This means that being on the birth control pill makes women a different version of themselves than when they are off of it. And this is a big deal. For instance, women on the pill have a dampened cortisol spike in response to stress. While this might sound great (no stress!), it can have negative implications for learning, memory, and mood. Additionally, because the pill influences who women are attracted to, being on the pill may inadvertently influence who women choose as partners, which can have important implications for their relationships once they go off it. Sometimes these changes are for the better . . . but other times, they're for the worse. By changing what women's brains do, the pill also has the ability to have cascading effects on everything and everyone that a woman encounters. This means that the reach of the pill extends far beyond women's own bodies, having a major impact on society and the world. This paradigm-shattering book provides an even-handed, science-based understanding of who women are, both on and off the pill. It will change the way that women think about their hormones and how they view themselves. It also serves as a rallying cry for women to demand more information from science about how their bodies and brains work and to advocate for better research. This book will help women make more informed decisions about their health, whether they're on the pill or off of it. |
| birth control hormone therapy: Contraception and Reproduction Working Group on the Health Consequences of Contraceptive Use and Controlled Fertility, 1989 Se estudian las consecuencias sanitarias de los diferentes patrones reproductivos en la salud de la mujer y de los niños. Tambien se evaluan el riesgo y los beneficios de los diferentes metodos anticonceptivos, aunque algunos de los datos en los que se basa son de paises desarrollados, el nucleo central del informe son los paises en desarrollo. |
| birth control hormone therapy: Contraceptive Research and Development Institute of Medicine, Committee on Contraceptive Research and Development, 1996-11-04 The contraceptive revolution of the 1960s and 1970s introduced totally new contraceptive options and launched an era of research and product development. Yet by the late 1980s, conditions had changed and improvements in contraceptive products, while very important in relation to improved oral contraceptives, IUDs, implants, and injectables, had become primarily incremental. Is it time for a second contraceptive revolution and how might it happen? Contraceptive Research and Development explores the frontiers of science where the contraceptives of the future are likely to be found and lays out criteria for deciding where to make the next R&D investments. The book comprehensively examines today's contraceptive needs, identifies niches in those needs that seem most readily translatable into market terms, and scrutinizes issues that shape the market: method side effects and contraceptive failure, the challenge of HIV/AIDS and other sexually transmitted diseases, and the implications of the women's agenda. Contraceptive Research and Development analyzes the response of the pharmaceutical industry to current dynamics in regulation, liability, public opinion, and the economics of the health sector and offers an integrated set of recommendations for public- and private-sector action to meet a whole new generation of demand. |
| birth control hormone therapy: Consultative Hemostasis and Thrombosis E-Book Craig S. Kitchens, Barbara A Konkle, Craig M. Kessler, 2013-02-20 A unique clinical focus makes Consultative Hemostasis and Thrombosis, 3rd Edition your go-to guide for quick, practical answers on managing the full range of bleeding and clotting disorders. Emphasizing real-world problems and solutions, Dr. Craig S. Kitchens, Dr. Barbara A. Konkle, and Dr. Craig M. Kessler provide all the clinical guidance you need to make optimal decisions on behalf of your patients and promote the best possible outcomes. Consult this title on your favorite e-reader with intuitive search tools and adjustable font sizes. Elsevier eBooks provide instant portable access to your entire library, no matter what device you're using or where you're located. Efficiently look up concise descriptions of each condition, its associated symptoms, laboratory findings, diagnosis, differential diagnosis, and treatment. Get the latest information on hot topics such as Disseminated Intravascular Coagulation, Thrombophilia, Clinical and Laboratory Assessment and Management, Thrombotic -Thrombocytopenic Purpura, and Heparin-Induced Thrombocytopenia. Apply today’s newest therapies, including those that are quickly becoming standard in this fast-changing field. Meet the needs of specific patient groups with a new chapter on Bleeding and the Management of Hemorrhagic Disorders in Pregnancy and an extensively updated chapter on Thrombosis and Cancer. Zero in on key information with a new user-friendly design, and all-new full-color format, abundant laboratory protocols, and at-a-glance tables and charts throughout. |
| birth control hormone therapy: The Immunoassay Handbook David Wild, 2013-01-21 The fourth edition of The Immunoassay Handbook provides an excellent, thoroughly updated guide to the science, technology and applications of ELISA and other immunoassays, including a wealth of practical advice. It encompasses a wide range of methods and gives an insight into the latest developments and applications in clinical and veterinary practice and in pharmaceutical and life science research. Highly illustrated and clearly written, this award-winning reference work provides an excellent guide to this fast-growing field. Revised and extensively updated, with over 30% new material and 77 chapters, it reveals the underlying common principles and simplifies an abundance of innovation. The Immunoassay Handbook reviews a wide range of topics, now including lateral flow, microsphere multiplex assays, immunohistochemistry, practical ELISA development, assay interferences, pharmaceutical applications, qualitative immunoassays, antibody detection and lab-on-a-chip. This handbook is a must-read for all who use immunoassay as a tool, including clinicians, clinical and veterinary chemists, biochemists, food technologists, environmental scientists, and students and researchers in medicine, immunology and proteomics. It is an essential reference for the immunoassay industry. Provides an excellent revised guide to this commercially highly successful technology in diagnostics and research, from consumer home pregnancy kits to AIDS testing.www.immunoassayhandbook.com is a great resource that we put a lot of effort into. The content is designed to encourage purchases of single chapters or the entire book. David Wild is a healthcare industry veteran, with experience in biotechnology, pharmaceuticals, medical devices and immunodiagnostics, which remains his passion. He worked for Amersham, Eastman-Kodak, Johnson & Johnson, and Bristol-Myers Squibb, and consulted for diagnostics and biotechnology companies. He led research and development programs, design and construction of chemical and biotechnology plants, and integration of acquired companies. Director-level positions included Research and Development, Design Engineering, Operations and Strategy, for billion dollar businesses. He retired from full-time work in 2012 to focus on his role as Editor of The Immunoassay Handbook, and advises on product development, manufacturing and marketing. - Provides a unique mix of theory, practical advice and applications, with numerous examples - Offers explanations of technologies under development and practical insider tips that are sometimes omitted from scientific papers - Includes a comprehensive troubleshooting guide, useful for solving problems and improving assay performancee - Provides valuable chapter updates, now available on www.immunoassayhandbook.com |
| birth control hormone therapy: Hepatotoxicity Hyman J. Zimmerman, 1999 Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury. |
| birth control hormone therapy: Clinical Gynecology Eric J. Bieber, Joseph S. Sanfilippo, Ira R. Horowitz, Mahmood I. Shafi, 2015-04-23 Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings. |
| birth control hormone therapy: Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research National Research Council, Division on Earth and Life Studies, Board on Life Sciences, Institute of Medicine, Board on Health Sciences Policy, Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research, 2007-03-22 It is widely understood that stem cell treatments have the potential to revolutionize medicine. Because of this potential, in 2004 California voters approved Proposition 71 to set up a 10-year, $3 billion program to fund research on stem cells. Under the direction of the California Institute for Regenerative Medicine, this program will pay to build facilities for stem cell research and will fund doctors and scientists to carry out research with the ultimate goal of helping to develop therapies based on stem cells. For this research to move forward, however, will require a steady supply of stem cells, particularly human embryonic stem cells. Those stem cells are collected from developing human embryos created from eggs-or oocytes-harvested from the ovaries of female donors. Thus much of the promise of stem cells depends on women choosing to donate oocytes to the research effort. The oocyte donation process is not without risk, however. Donors are given doses of hormones to trigger the production of more eggs than would normally be produced, and this hormone treatment can have various side effects. Once the eggs have matured in the ovary, they must be retrieved via a surgical procedure that is typically performed under anesthesia, and both the surgery and the anesthesia carry their own risks. Furthermore, given the very personal nature of egg donation, the experience may carry psychological risks for some women as well. With this in mind, in 2006 the California Institute for Regenerative Medicine contracted with the National Academies to organize a workshop that would bring together experts from various areas to speak about the potential risks of oocyte donation and to summarize what is known and what needs to be known about this topic. The Committee on Assessing the Medical Risks of Human Oocyte Donation for Stem Cell Research was formed to plan the workshop, which was held in San Francisco on September 28, 2006. This report is a summary and synthesis of that workshop. |
| birth control hormone therapy: Drug-Induced Liver Injury , 2019-07-13 Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series |
| birth control hormone therapy: Hormone Intelligence Aviva Romm, M.D., 2021-06-08 INSTANT NEW YORK TIMES BESTSELLER • WALL STREET JOURNAL BESTSELLER • #1 GLOBE AND MAIL BESTSELLER • USA TODAY BESTSELLER You are not broken. Being a woman is not a diagnosis. Take your body back with the groundbreaking new science for women in Hormone Intelligence. Hormonal. We all know what it means when we hear it – and feel it. While hormonal shifts are natural throughout women’s lives, too many experience distressing period symptoms, struggle daily with PCOS, endometriosis, a fertility challenge, pain, low sex drive, sleep problems, acne, bloating, hot flashes, and more – all due to hormone-related problems. And too many are unable to get the answers they’re really seeking from their doctors. There is a solution. In Hormone Intelligence, Yale trained and internationally renowned women’s health expert, Dr. Aviva Romm, helps you identify the root causes of your symptoms and guides you through a 6-week proven program to achieve lifelong hormonal and gynecologic health. Using a holistic, dietary and lifestyle changing approach, Hormone Intelligence goes beyond treating symptoms to the deeper factors impacting women’s health, so you can reclaim your body, hormones, and self. Inside Hormone Intelligence, you’ll find: · Hormone Health 101: Understand the key components of the hormone epidemic and associated dietary and lifestyle triggers. · Symptoms and Root Causes Demystified: Discover what your symptoms are saying about your hormones with quizzes, checklists, trackers, and more. · A 6-Week Action Plan: Learn what foods you should indulge and avoid, how to repair your microbiome to support hormone health, how to identify environmental hormone disruptors, engage your body’s natural detoxification systems and reduce hidden inflammation, and the lifestyle changes that lead to happy, healthy hormones. · Delicious, done-for-you meal plans to take you through the entire program, including vegan options. Hormone Intelligence is an invitation to a whole new relationship with your body and hormones, the exhale you’ve been waiting for, and the first step on the road to realizing that a diagnosis does not have to be your destiny. Extended references, a complete index, and additional resources for Hormone Intelligence can be found at the author's website. |
| birth control hormone therapy: The Doctor's Case Against the Pill Barbara Seaman, 1995 Considered the definitive statement on modern birth-control technologies, this Anniversary Edition includes new, up-to-date chapters on the dangers of Norplant and the risks women on the Pill face today. Because it tells the truth about the Pill, this book provides women with the information they need to make good choices for their own body. |
| birth control hormone therapy: Synthesis of Essential Drugs Ruben Vardanyan, Victor Hruby, 2006-03-10 Synthesis of Essential Drugs describes methods of synthesis, activity and implementation of diversity of all drug types and classes. With over 2300 references, mainly patent, for the methods of synthesis for over 700 drugs, along with the most widespread synonyms for these drugs, this book fills the gap that exists in the literature of drug synthesis. It provides the kind of information that will be of interest to those who work, or plan to begin work, in the areas of biologically active compounds and the synthesis of medicinal drugs. This book presents the synthesis of various groups of drugs in an order similar to that traditionally presented in a pharmacology curriculum. This was done with a very specific goal in mind – to harmonize the chemical aspects with the pharmacology curriculum in a manner useful to chemists. Practically every chapter begins with an accepted brief definition and description of a particular group of drugs, proposes their classification, and briefly explains the present model of their action. This is followed by a detailed discussion of methods for their synthesis. Of the thousands of drugs existing on the pharmaceutical market, the book mainly covers generic drugs that are included in the WHO's Essential List of Drugs. For practically all of the 700+ drugs described in the book, references (around 2350) to the methods of their synthesis are given along with the most widespread synonyms. Synthesis of Essential Drugs is an excellent handbook for chemists, biochemists, medicinal chemists, pharmacists, pharmacologists, scientists, professionals, students, university libraries, researchers, medical doctors and students, and professionals working in medicinal chemistry. * Provides a brief description of methods of synthesis, activity and implementation of all drug types* Includes synonyms* Includes over 2300 references |
| birth control hormone therapy: Women and Health Marlene B. Goldman, Rebecca Troisi, Kathryn M. Rexrode, 2012-12-31 Women and Health is a comprehensive reference that addresses health issues affecting women of all ages — from adolescence through maturity. It goes far beyond other books on this topic, which concentrate only on reproductive health, and has a truly international perspective. It covers key issues ranging from osteoporosis to breast cancer and other cancers, domestic violence, sexually transmitted diseases, occupational hazards, eating disorders, heart disease and other chronic illnesses, substance abuse, and societal and behavioral influences on health. In this second edition of Women and Health, chapters thoughtfully explore the current state of women's health and health care, including the influences of sex and gender on the occurrence of a wide variety of diseases and conditions. All chapters have been extensively updated and emphasize the epidemiology of the condition — the etiology, occurrence, primary and secondary prevention (screening), risk factors, surveillance, changing trends over time, and critical analysis of the diagnostic and treatment options and controversies. Treatment sections in each chapter have been expanded to create a stronger dialogue between epidemiologists and women's health practitioners. - Saves researchers and clinicians time in quickly accessing the very latest details on a broad range of women's health issues, as opposed to searching through thousands of journal articles - Provides a common language for epidemiologists, public health practitioners, and women's health specialists to discuss the behavioral, cultural, and biological determinants of women's health - Researchers and medical specialists will learn how the gender-specific risks and features of one organ system's diseases affect the health of other organ systems - For example: Hormone replacement therapy used to treat imbalance within the endocrine system is also being used to prevent and treat cardiovascular disease; Drugs developed for type 2 diabetes are now being used in chemoprevention - Orients the non-gerontologist about the importance of considering the entire life cycle of women within research designs and treatment plans - Professors teaching courses in women's health will use slides and additional materials to structure lectures/courses; students will use slides as a unique resource to study for exams |
| birth control hormone therapy: Current Contraceptive Status Among Women Aged 15-44;: United States, 2011-2013 Kimberly Daniels, 2014 |
| birth control hormone therapy: The Promise of Adolescence National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Division of Behavioral and Social Sciences and Education, Board on Children, Youth, and Families, Committee on the Neurobiological and Socio-behavioral Science of Adolescent Development and Its Applications, 2019-07-26 Adolescenceâ€beginning with the onset of puberty and ending in the mid-20sâ€is a critical period of development during which key areas of the brain mature and develop. These changes in brain structure, function, and connectivity mark adolescence as a period of opportunity to discover new vistas, to form relationships with peers and adults, and to explore one's developing identity. It is also a period of resilience that can ameliorate childhood setbacks and set the stage for a thriving trajectory over the life course. Because adolescents comprise nearly one-fourth of the entire U.S. population, the nation needs policies and practices that will better leverage these developmental opportunities to harness the promise of adolescenceâ€rather than focusing myopically on containing its risks. This report examines the neurobiological and socio-behavioral science of adolescent development and outlines how this knowledge can be applied, both to promote adolescent well-being, resilience, and development, and to rectify structural barriers and inequalities in opportunity, enabling all adolescents to flourish. |
| birth control hormone therapy: HPV and Cancer James A. Radosevich, 2012-12-14 “HPV and Cancer” is a concise read that covers all aspects of the Human Papilloma Virus as it relates to human cancers. While written by professionals, it design to be understandable by those that are not in the field, yet it has the technical details that professionals want to stay abreast of this changing field. The book starts out the history of HPV and progresses into the molecular biology of the virus and our current understand of the structure and functions of the proteins and genes it encodes. We then look at the dynamic trends of this infectious agent in the human population, how it interacts with human cells, and the role it plays with other organisms to produce both benign and malignant tumors. Lastly, there is a discussion about a new vaccine for HPV and the hopes that are held by many to change the trends with this virus and the associated cancers it produces. |
| birth control hormone therapy: Contraceptive Use by Method 2019 United Nations, 2020-01-10 This data booklet highlights estimates of the prevalence of individual contraceptive methods based on the World Contraceptive Use 2019 (which draws from 1,247 surveys for 195 countries or areas of the world) and additional tabulations obtained from microdata sets and survey reports. The estimates are presented for female and male sterilisation, intrauterine device (IUD), implant, injectable, pill, male condom, withdrawal, rhythm and other methods combined. |
| birth control hormone therapy: Botanical Medicine for Women's Health E-Book Aviva Romm, 2017-01-25 Use herbal medicines to treat women at any stage of life! Botanical Medicine for Women's Health, 2nd Edition provides an evidence-based, patient-centered approach to botanical interventions for many different medical conditions. More than 150 natural products are covered, showing their benefits in gynecologic health, fertility and childbearing, and menopausal health. This edition includes new full-color photos of herbal plants along with a discussion of the role of botanicals in healthy aging. Written by Aviva Romm, an experienced herbalist, midwife, and physician, this unique guide is an essential resource for everyday practice of herbal medicine. Winner of the 2010 American Botanical Council's James A. Duke Excellence in Botanical Literature Award! - Current, evidence-based information covers more than 150 botanicals for over 35 different conditions. - Case studies provide realistic scenarios and help you apply the content to the real world. - Treatment and formula boxes summarize the most important information. - Color illustrations and photographs of plants enable you to identify herbs visually as well as by substance make-up. - Logical chapter organization begins with the principles of herbal medicine and then covers women's health conditions organized chronologically by lifecycle, from teen and reproductive years to midlife and mature years. - Appendices include practical, at-a-glance information on common botanical names, chemical constituents of medicinal plants, and a summary table of herbs for women's health. - NEW! Updates reflect the latest research and the most current information. - NEW Full-color design and detailed, professional color photos of plants make this a unique, essential resource. - NEW! Coverage of the role of botanicals in healthy aging for women features phytoestrogens, Ayurvedic/Chinese herbs, and discussions of health promotion. |
| birth control hormone therapy: The Menopausal Transition Claudio N. Soares, Michelle P. Warren, 2009-01-01 The interplay of hormones, health and behavior across the female life cycle, especially during the menopausal transition, poses a special challenge to health care professionals.Written by experts, this book brings together the knowledge gained on the menopausal transition from clinical experience and medical research. Topics like 'what to expect' from the menopausal transition, sexuality, sociocultural changes, impact of life stressors, and emergence of depression are discussed. The physiology of thermoregulation and the occurrence of hot flashes are reviewed for a better understanding of vasomotor complaints. Another chapter offers an update on hormonal and nonhormonal treatment strategies by presenting an overview of the management of mood and anxiety during the menopausal transition. The emergence of psychotic symptoms associated with peri- and postmenopausal changes in sex hormone levels is also addressed. Lastly, the book includes an excellent review on the pros and cons of hormonal therapy in the post-Women's Health Initiative era. This book is a must for gynecologists, psychiatrists, endocrinologists, epidemiologists involved in the clinical care of mature women as well as researchers and students interested in obtaining an up-to-date overview of this topic. |
| birth control hormone therapy: Contraception and Adolescents Robert T. Brown, Paula K. Braverman, 2005 This issue will provide an update on contraception for adolescents. The content will include an overview of contraceptive practices among adolescents with specific articles on hormonal and nonhormonal methods including barrier contraceptives, emergency contraception and the IUD. One article will address contraceptive issues for teens in the developing world. The issue will also include a review of the noncontraceptive benefits of hormonal methods and potential interactions with other medications including herbal products. Specific concerns for teens with chronic illnesses and disabilities will be discussed along with new contraceptive methods under development. |
| birth control hormone therapy: Body Composition and Physical Performance Institute of Medicine, Committee on Military Nutrition Research, 1992-02-01 This book surveys the entire field of body composition as it relates to performance. It includes a clear definition of terminology and a discussion of the various methods for measuring body composition. The authored papers represent a state-of-the-art review of this controversial field and address questions such as: What is a better measure of body compositionâ€body fat or lean body mass? Does being overweight for one's height really affect performance? The book also addresses the issue of physical appearance as it relates to body fatness and performance. It includes an in-depth discussion of many of the topics of interest to those involved in sports medicine and exercise physiology. |
| birth control hormone therapy: A Clinical Guide for Contraception Leon Speroff, Philip D. Darney, 2011 The thoroughly updated Fifth Edition of this practical handbook provides the essential information that clinicians and patients need to choose the best contraceptive method for the patient's age and medical, social, and personal characteristics. |
| birth control hormone therapy: Progesterone and Progestins C. Wayne Bardin, Edwin Milgröm, P. Mauvais-Jarvis, 1983 |
| birth control hormone therapy: Beyond the Pill Jolene Brighten, 2019-01-29 All women need to read this book.—Dave Asprey, author of The Bulletproof Diet Groundbreaking solutions for the common hormonal struggles women face both on and off birth control.—Amy Medling, founder of PCOS Diva and author of Healing PCOS A natural, effective program for restoring hormone balance, normalizing your period, and reversing the harmful side effects of ‘The Pill’—for the millions of women who take it for acne, PMS, menstrual cramps, PCOS, Endometriosis, and many more reasons other than contraception. Out of the 100 million women—almost 11 million in the United States alone—who are on the pill, roughly 60 percent take it for non-contraceptive reasons like painful periods, endometriosis, PCOS, and acne. While the birth control pill is widely prescribed as a quick-fix solution to a variety of women’s health conditions, taking it can also result in other more serious and dangerous health consequences. Did you know that women on the pill are more likely to be prescribed an antidepressant? That they are at significantly increased risk for autoimmune disease, heart attack, thyroid and adrenal disorders, and even breast and cervical cancer? That the pill can even cause vaginal dryness, unexplained hair loss, flagging libido, extreme fatigue, and chronic infection. As if women didn’t have enough to worry about, that little pill we’re taking to manage our symptoms is only making things worse. Jolene Brighten, ND, author of the groundbreaking new book Beyond the Pill, specializes in treating women’s hormone imbalances caused by the pill and shares her proven 30-day program designed to reverse the myriad of symptoms women experience every day—whether you choose to stay on the pill or not. The first book of its kind to target the birth control pill and the scientifically-proven symptoms associated with taking it, Beyond the Pill is an actionable plan for taking control, and will help readers: Locate the root cause of their hormonal issues, like estrogen dominance, low testosterone, and low progesterone Discover a pain-free, manageable period free of cramps, acne, stress, or PMS without the harmful side effects that come with the pill Detox the liver, support the adrenals and thyroid, heal the gut, reverse metabolic mayhem, boost fertility, and enhance mood Transition into a nutrition and supplement program, with more than 30 hormone-balancing recipes Featuring simple diet and lifestyle interventions, Beyond the Pill is the first step to reversing the risky side effects of the pill, finally finding hormonal health, and getting your badass self back. |
| birth control hormone therapy: Cardiovascular Disease and Steroid Hormone Contraception , 1998 Evaluates the strength and significance of evidence linking use of combined oral contraceptives to an increased risk of cardiovascular disease in women. Recommendations and conclusions reflect the consensus reached by a group of scientists, including researchers directly involved in several recent large-scale investigations of cardiovascular disease and hormone contraception. The experts also considered evidence that other factors, such as smoking, hypertension, diabetes, age, and family history, might influence the risk of cardiovascular disease in users of combined oral contraceptives. In view of major recent changes in the hormonal content of these contraceptives and the prescribing patterns of providers, the assessment concentrates on data collected after 1980. The experts also aimed to determine whether the risk of disease is influenced by the estrogen or progestogen content of different preparations. To facilitate the comparison and interpretation of study results, the report opens with a discussion of the strengths and weaknesses of the different epidemiological approaches used to assess the safety of steroid contraceptives. Also discussed is the important distinction between the use of relative risk to examine epidemiological associations and the use of absolute risk to examine clinical importance. Against this background, the main part of the report examines the strength of evidence linking steroid contraceptives to an increased risk of acute myocardial infarction, ischaemic stroke, haemorrhagic stroke, and venous thromboembolism. Studies of combined oral contraceptives and progestogen-only contraceptives are considered separately for each disease. An effort is also made to determine whether conclusions, based on studies conducted in industrialized countries, are also valid for women living in the developing world. The assessment of findings from epidemiological studies is complemented by a review of possible biological explanations for the effects of combined oral contraceptives on cardiovascular functions. On the basis of all available evidence, the report concludes that mortality rates from cardiovascular disease are extremely low among women of reproductive age and that the added risk of using steroid contraceptives is also very low in users who do not smoke or have other risk factors for cardiovascular disease. A final section places these risks in perspective and offers balanced advice useful to providers of family planning when helping women to make informed choices about the use of hormonal contraceptives. |
| birth control hormone therapy: The Hormone Diet Natasha Turner, 2010-07-06 Outlines a three-step program designed to correct hormonal imbalances for potential health benefits, explaining how to identify problem areas in order to address such challenges as weight gain, insomnia, and mood disorders. |
| birth control hormone therapy: Liver Carcinogenesis , 1979 |
| birth control hormone therapy: The Benefits and Risks of Oral Contraceptives Today James O. Drife, 1996 This is the new edition of Professor James Owen Drife's elegantly illustrated, full-color, large-format booklet explaining the true modern-day risks and benefits of low-dose combined oral contraceptives. It cites over 70 medical and scientific references in presenting up-to-date information that often disagrees with early studies and with reports in the lay press. It also documents the non-contraceptive benefits of the pill-benefits that have received little publicity but are important to women's health. The book's five main sections cover human fertility and contraceptives, the clinical pharmacology of oral contraceptives, and their risks, benefits, and controversies. Color photographs and figures highlight the key points of each chapter to help make this an exceptionally readable and informative work for physicians and their patients. Though lavishly produced, the book is priced low for consumers. |
| birth control hormone therapy: Directory of Hormonal Contraceptives Ronald Louis Kleinman, International Planned Parenthood Federation, 1992 |
| birth control hormone therapy: Contraception John Guillebaud, 2004 This volume provides a primary source of information about reversible methods of contraception in a question and answer format. This edition covers new developments including the patch, injection, the mini pill and Cerazette and incorporates the new guidance on 'missed pills' from the WHO. |
| birth control hormone therapy: Human Sexuality and Its Problems John Bancroft, 1989 This is an updated multidisciplinary and scholarly account of the determinants of human sexuality including sexual development, anatomy and physiology, biochemistry and endocrinology of sexual behaviour in addition to sociological and psychological aspects. |
| birth control hormone therapy: Office Practice of Neurology Martin A. Samuels, Steven K. Feske, 2003 This comprehensive text is the perfect clinical resource, offering quick access to all of the information needed to provide out-patient neurologic care. It focuses on the common and chronic problems that require long-term management, and provides step-by-step guidance on the decision-making process. Readers will find an expanded section on multiple sclerosis as well as updated and revised information in every section, including all of the latest studies and their results. Plus, a table at the beginning of each chapter summarizes the authors' approaches to diagnosis and management. Features contributions from more than 200 authors, representing a wide spectrum of specialists in neurology and related fields. Covers the major problems that any practicing neurologist might encounter, including those that may be rare. Presents a wealth of useful clinical information with enough comprehensive coverage on the difficult, long-term, and complicated disorders. Features an expanded section on multiple sclerosis, with in-depth discussions on the clinical issues surrounding the disease. Discusses the latest molecular genetic studies, including new information on the progressive ataxias · Alzheimer's disease · Huntington's disease · mitochondrial disorders · and familial stroke and headache syndromes. Reports on the results of recent clinical studies on asymptomatic carotid atherosclerosis and symptomatic carotid endarterectomy. Includes the latest methods for treating stroke · seizures · multiple sclerosis · migraine · Parkinson's disease · amyotrophic lateral sclerosis · and Alzheimer's disease. Presents a summary table at the beginning of each chapter, highlighting the authors' approaches to various problems of diagnosis and management. |
| birth control hormone therapy: The Menopause David H. Barlow, David Hearnshaw Barlow, 1996 Covering the key issues of the menopause, this text deals with such topics as: the menopausal transition; the uterus and the menopause; the menopause and the skeleton; hormone replacement therapy - present and future; and the urogenital effects of the menopause. |
| birth control hormone therapy: The Walnut Creek Contraceptive Drug Study Savitri Ramcharan, 1974 |
| birth control hormone therapy: Period Repair Manual Lara Briden, 2020 |
| birth control hormone therapy: Combined Estrogen-progestogen Contraceptives and Combined Estrogen-progestogen Menopausal Therapy IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, International Agency for Research on Cancer, 2007 Oral contraceptives for family planning worldwide have revolutionized the reproductive lives of millions of women since their introduction in the 1960s. Later on, a variety of side-effects including cardiovascular diseases was recognized. In response to these concerns, new generations of combined oral contraceptives were developed that featured lower dose of estrogen and newer, more potent progestogens. The effectiveness and ease of use of combined hormonal contraceptives suggest that they will continue to be used to a significant extent in the future. This ninety-first volume of IARC Monograp. |
| birth control hormone therapy: Facts about Menopausal Hormone Therapy (rev. Ed. ) Barry Leonard, 2008-10 Menopausal hormone therapy once seemed the answer for many of the conditions women face as they age. It was thought that hormone therapy could ward off heart disease, osteoporosis, and cancer, while improving women¿s quality of life. But beginning in July 2002, findings emerged from clinical trials that showed this was not so. In fact, long-term use of hormone therapy poses serious risks and may increase the risk of heart attack and stroke. This report discusses those findings and gives an overview of such topics as menopause, hormone therapy, and alternative treatments for the symptoms of menopause and the various health risks that come in its wake. It also provides a list of sources you can contact for more information. Illustrations. |
Woman giving birth: Live birth video | BabyCenter
Apr 25, 2025 · Since natural birth can be intense, having a strong support system (partner, doula, or loved one) and using pain-relief techniques like warm baths, breathing exercises, and massage …
Birth - Wikipedia
Birth is the act or process of bearing or bringing forth offspring, [1] also referred to in technical contexts as parturition. In mammals, the process is initiated by hormones which cause the …
BIRTH Definition & Meaning - Merriam-Webster
The meaning of BIRTH is the emergence of a new individual from the body of its parent. How to use birth in a sentence.
BIRTH | English meaning - Cambridge Dictionary
BIRTH definition: 1. the time when a baby or young animal comes out of its mother's body: 2. a child that is born…. Learn more.
Birth | Definition, Stages, Complications, & Facts | Britannica
May 30, 2025 · Birth, process of bringing forth a child from the uterus, or womb. The three stages of labor are dilatation, expulsion, and the placental stage. Learn more about these stages, the …
Stages of labor and birth: Baby, it's time! - Mayo Clinic
Jul 23, 2024 · Stages of labor and birth: Baby, it's time! Labor is a natural process. Here's what to expect during the stages of labor and birth — along with some tips to make labor more …
Is it possible to boost the US birth rate? Here’s what ... - The Hill
12 hours ago · People and policymakers may want to boost the birth rate for a variety of reasons, from cultural to economic. The primary economic concern is that if a country’s birth rate drops …
Childbirth - Wikipedia
Childbirth, also known as labour, parturition and delivery, is the completion of pregnancy, where one or more fetuses exits the internal environment of the mother via vaginal delivery or caesarean …
Everything You Need to Know About Giving Birth - Verywell Health
Dec 29, 2023 · Giving birth is the process of pushing the baby out from your uterus. When you are ready to do that, you will go through labor, which consists of three stages. Signs like contractions …
Childbirth | Stages of Labor | Effacement - MedlinePlus
May 19, 2025 · Childbirth is the process of having a baby. Learn about the 3 stages of labor, and how you can prepare, tell if you are in labor, and manage the pain.
Female Estradiol & Testosterone Pellet Insertion Consent
Patients who are not sterilized and are not menopausal are REQUIRED to continue a reliable birth control method while participating in hormone replacement therapy and/or peptide therapy. …
What You Should Know About: HIV, PrEP, and You
• If you are on birth control, hormone therapy, are pregnant, or even are breastfeeding, you can still take PrEP safely. Be Your Own . Health Advocate! Use your Medicaid benefits to help you …
Feminizing Hormone Therapy for Gender Transition
Hormone therapy can have a positive effect on your life and your journey with gender affirmation. ... chemicals control many of your body’s functions, such as growth, sex drive, hunger, fat …
Homepage - Partners in Contraceptive Choice and Knowledge
Progestin hormone Progestin and estrogen hormones No hormones How often to use/take/change Contraception (Birth Control) Guide Start and stop on your own PïCCk 2022 …
Bioidentical Hormone Replacement Therapy (BHRT) …
HORMONE TREATMENT. My birth control method is _____. Physical and Aesthe c Medicine reserves the right to discharge a pa ent who exhibits non-compliance with the hormone …
Drug interactions between rifamycin antibiotics and hormonal ...
contraceptive steroid hormone or the rifamycin drug that reported area under the curve (AUC), maximum serum concentration (Cmax), minimum serum concentration (Cmin) or mean 24 …
Table I. Examples of Hormone and Tapering Regimens
response with hormone treatment; Too rapid a taper results in withdrawal bleeding; For nausea, vomiting + anti-emetic; Consider extended cycling; Avoid low dose 20-25mcg E2 ... Less …
Feminizing Gender-Affirming Hormone Care - Wicha Lab
The primary hormone we use for feminizing hormone therapy is estradiol . Estradiol is a human-made hormone that is very similar to the hormones produced by the human body (a …
transition-related hormone therapy - Rainbow Health Ontario
Masculinizing and feminizing hormone therapy regimens have variable temporary and long-term impacts on fertility. Accordingly, there is a need for discussion regarding both birth control and …
PELLET INSERTION CONSENT FORM - Pro-Pell Therapy …
replacement. The pellet method of hormone replacement therapy has been used in Europe and Canada for many years and by select OB/GYN physicians in the United States. Patients who …
Your DUTCH Cycle Mapping™ PLUS Kit Includes - DUTCH Test
hormonal birth control, hormone replacement therapy or are post-menopausal, unless otherwise instructed by your healthcare practitioner. **If you are taking hormone therapy, specifically …
Cornell Gender-Afrming Hormones: Health Testosterone
Hormone therapy will not change some body features. A person’s bone structure or height will not change. Breast/chest size will not decrease or go away. Hormone therapy is not the only way …
Your DUTCH Cycle Mapping™ PLUS Kit Includes
hormonal birth control, hormone replacement therapy or are post-menopausal, unless otherwise instructed by your healthcare practitioner. **If you are taking hormone therapy, specifically …
Cancer Center of Western Wisconsin
Hormonal birth control before menopause. Hormone therapy (H T). Antidepressants. Clonidine. Gabapentin. Other treatments that may help include cognitive behavioral therapy, hypnosis, …
Checklist for Blood Clot Risk Factors - Centers for Disease …
Use of birth control methods that contain estrogen, such as the pill, patch or ring Pregnancy, which includes the six weeks after the baby is born The use of hormone therapy with estrogen …
Risks and Beneffts of Estrogen and Spironolactone - Fenway …
Estrogen therapy is not a method of birth control. There is no way to predict when or if a person will become infertile (unable to get someone pregnant) when taking estrogen. Oth-er birth …
Women's Health Baseline
The next questions are about hormone replacement therapy. That is the use of estrogen or other hormones for women who have gone through or are going through menopause, or to treat …
Shrewsbury Surgery Center - One Medical Passport
Birth control / hormone therapy Pregnancy and up to 6 weeks after giving birth Heart Disease/Cancer Obesity Clotting disorder Smoking Family history of VTE History of a blood …
If you are scheduled for a medication abortion, you MUST It is ...
If you are seeking an appointment to begin gender affirming hormone therapy, you may schedule online if you are 18 years or older. If you are under 18 years old, please call 757-271-6437 for …
Thyroid Hormone Treatment FAQ - American Thyroid …
Medications that may cause a change in your T4 dose include birth control pills, estrogen, testosterone, some anti-seizure medications, and some medications for ... Thyroxine can also …
PATIENT & CAREGIVER EDUCATION Ethinyl Estradiol and …
use like hormonal birth control. Hormone replacement therapy (HRT): If you have had your uterus removed. This is not a list of all drugs or health problems that interact with this drug. Tell your …
Elevated hCG can be a benign fi nding in perimenopausal and ...
hCG suppression after 3 weeks of hormone therapy. High-estrogen birth control pills con-taining 50 μg of ethinyl estradiol plus proges-terone are recommend. Hormone therapy can be …
Name / MR # / Label
Name: Date of Birth: Date of Last Period: Implants? None / Silicone / Saline Do you take Birth Control, Hormone Replacement or Hormone Therapy? (circle if appropriate). Do you have a …
What You Should Know About: HIV, PrEP, and You - New …
• If you are on birth control, hormone therapy, are pregnant, or even are breastfeeding, you can still take PrEP safely. Be Your Own . Health Advocate! Use your Medicaid benefits to help you …
EFFECTS OF FEMINIZING HORMONE THERAPY (ESTROGEN)
In order to receive cross-sex hormone therapy through our clinic, a person must: (1) Have a persistent, serious desire to modify their body by taking hormones that align with their gender …
Mammography Intake Form - TopLine MD
Are you currently taking hormones (i.e. birth control, hormone replacement therapy)? ☐ Yes ☐ No Have you ever been pregnant? ☐ Yes ☐ No How old were you when you delivered your first …
Patient Information for FEMINIZING HORMONE THERAPY …
most effective, people take not only estrogens (hormone associated with people assigned female at birth), but also medicines to block their body from producing or utilizing testosterone …
Title: Colorado Minor Consent Law Quick Reference Chart
• With the minor’s consent, a physician may give birth control procedures, information and supplies to any minor of any age who requests and is in need of them. Colo. Rev. Stat. § 13 …
ALESSE 28 Tablets (levonorgestrel and ethinyl estradiol tablets ...
levonorgestrel to sex hormone binding globulin (SHBG), which is attributed to increased SHBG levels that are induced by the daily administration of ethinyl estradiol. Following a single dose, …
Adolescent dosing guide 5.31.24 - Johns Hopkins Medicine
} ] v P ' µ ] W ' v ( ( ] u ] v P , } u } v d Z Ç & } d v P v v ' v ] À } o v
POCKET GUIDE MENOPAUSE MANAGEMENT
the risks of hormone therapy in symptomatic women. Instead, they were designed to find out whether the ben-efits of hormone therapy seen in observational studies of younger …
Birth Control Options - Planned Parenthood
hormone therapy - Testing & treatment for UTIs - Fertility evaluation & treatment Planned Parenthood provides a full range of ... Most side effects from hormonal birth control go away …
Oral Contraceptives Handout - University of New Hampshire
The name of your birth control pill is _____ Your birth control pills contain synthetic estrogen and progestret. Estrogen is the hormone that prevents shedding of the uterine lining (bleeding). …
YOUR LIFE. YOUR JOURNEY. CHOOSE LILETTA
for up to 5 years in women who choose to use birth control placed in the uterus. LILETTA is an intrauterine system, or IUS, otherwise known as an IUD, intrauterine device. YOUR LIFE. …
Gender-Affirming Hormones Estrogen and Androgen
• Estrogen therapy is not a method of birth control. There is no way to predict when or if a person will become infertile (unable to get someone pregnant) when taking estrogen. Other birth …
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION …
back-up method of birth control (such as latex or polyurethane condoms or spermicide) should be used during those 7 days. LOLO is effective from the first day of therapy if the tablets are …
You’ve been prescribed NEXTSTELLIS here’s what’s next…
When you use birth control that contains hormones, you’re more likely to develop blood clots – the most common serious side effect of birth control pills. This risk is highest during the first year …
Hormone Resource Guide Testosterone copy - Whitman …
• Gender affirming hormone therapy may affect someone’s ability to be pregnant or overall fertility. Someone who wishes to become ... • Testosterone is not a form of birth control, nor does it …
BILL AS INTRODUCED H.659 2022 Page 1 of 4 - Vermont
18 A minor who identifies as transgender may give consent to receive hormone 19 blockers and any other legally authorized nonsurgical, gender-affirming care or 20 treatment from a licensed …
Information about Masculinizing Hormone Treatment
There are four areas where you can expect changes to occur as your hormone therapy progresses. 1) Physical The first changes you will probably notice are that your skin will …
450038-02V1 TEMP 1-2 - Clearblue
breastfeeding, are taking hormonal birth control, hormone replacement therapy, medications a˜ecting FSH, have PCOS, or after surgical procedures which a˜ect your cycle. The test …
A Guide to Feminizing Hormones - CHCW
Feminizing hormone therapy varies greatly from person to person. There is no right hormone combination, type, or dose for everyone. Deciding what to take depends on your health …
CALIFORNIA MINOR CONSENT AND CONFIDENTIALITY …
A minor may receive birth control without parental consent. (Cal. Family Code § 6925). ABORTION A minor may consent to an abortion without parental consent. (Cal. Family Code § …
What You Should Know About: HIV, PrEP, and You
• If you are on birth control, hormone therapy, are pregnant, or even are breastfeeding, you can still take PrEP safely. Be Your Own . Health Advocate! Use your Medicaid benefits to help you …
CANADIAN STROKE BEST PRACTICE RECOMMENDATIONS
(Physical Activity, Weight Management, Oral Contraceptives, Hormone Replacement Therapy, Air Pollution, Behaviour Management) Gladstone D, Poppe A (Writing Group Chairs) on Behalf of …
PatientPop
Family planning/Birth Control Hormone replacement therapy Age of -1st menstrual period First day of last menstrual period? How many days apart are your cycles? ... Are you using any …
MRS Title 22, Chapter 260. CONSENT OF MINORS FOR …
§1508. Consent for gender-affirming hormone therapy 1. Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings. A. …
Do not try anything new at Philmont. Be sure to have had
Birth Control/Hormone Therapy- If you are already on birth control, you can try timing the medication to reduce the chance of a period on the trail. Do not start birth control just to control …
What You Should Know About: HIV, PrEP, and You
• If you are on birth control, hormone therapy, are pregnant, or even are breastfeeding, you can still take PrEP safely. Be Your Own . Health Advocate! Use your Medicaid benefits to help you …
Health & Wellbeing - transequality.org
including preventive care, birth control, fertility options in the context of gender-affirming care, access to safe abortion, and prevention and treatment ... shares of hormone therapy denials at …
